GVB Biopharma’s Post

On Thursday I will talk (virtually) about Estimands, target trial emulation, and use of external control data at the annual meeting of the Danish Society for Biopharmaceutical Statistics. Thanks Christian Pipper for the invitation! The announcement is linked in the comments. There is no virtual option, but maybe some of my Danish colleagues can make the event. The talk is based on a paper led by Letizia Polito, PhD. #biostatistics #estimands #realworlddata

We know the "Secret Ingredient" for pushing the discovery targets faster towards clinic. Write to Sarah Chatterjee to know more at sarah@dev-synthesis.com Dev-Synthesis Dev-Synthesis

Unlock the Future of Biotech and Pharma with Glaesernes Labor Akademie Are you passionate about the biotech and pharmaceutical industries? Discover the cutting-edge programs offered by Glaesernes Labor Akademie designed to equip you with the skills and knowledge to thrive in these rapidly evolving fields. Explore the courses and opportunities here: Glaesernes Labor Akademie - Biotech & Pharma Let’s connect and discuss how these programs can benefit your career or your organization’s growth.

👉 Find attached this interesting interview with Ana Nunes, our Global Business Development Director, 🌍 discussing about the #growth of Zinereo Pharma and its #international expansion. An interview for the Portuguese magazine Pontos de Vista. 🦠 Zinereo Pharma, a company of the biotechnological ZENDAL group, stands for its strong pharmaceutical DNA. Our slogan, "lifeforLIFE” reflects our commitment for contributing to a healthier #life, the #human #LIFE, through one of the most simple forms of life, the #bacteria. 🦠 We develop #probiotic solutions guided by #innovation, always with a #scientific approach, which is based on three fundamental #pillars: quality, efficacy and safety. Read more! 👉 #lifeforLIFE

Thoughts on this? >> SK Bioscience takes majority stake in CDMO for $244M; Ex-Lonza CEO joins Cytiva >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #biotech #pharma #productmarketing

Global Central Lab Market Size, Share & Trends Analysis Report 2024-2030 - Profiles of LabConnect, Cerba Research, Eurofins Scientific, Ampersand Capital Partners & CIRION BioPharma Research: DUBLIN, Jan. 11, 2024 /PRNewswire/ -- The "Global Central Lab Market Size, Share & Trends Analysis Report by Service (Genetic Services, Biomarker Services), End-use (Pharmaceutical Companies, Biotechnology Companies), Region, and Segment Forecasts, 2024-2030" report has been added to...

Salipro Biotech and Top10 Japanese Pharma Company Expand Multi-Target Research Collaboration Salipro Biotech AB today announced the expansion of its multi-target research collaboration with a Top10 Japanese pharmaceutical company. Building on our successful research program, this extended agreement includes additional drug targets and projects, leveraging our proprietary Salipro® platform technology. The expanded collaboration will focus on a range of challenging membrane protein drug targets, such as GPCRs, ion channels and transporters. Salipro Biotech’s expertise in membrane protein stabilisation will be instrumental in advancing drug discovery programs for these targets. We are excited to expand our research programs and to continue pushing the boundaries of drug discovery. #Salipro #Pharma #DrugDevelopment #SaliproBiotech #Japan

📢Biogen's CDMO revenues to plummet after Denmark 📢 Biogen, a global biotech company, expects its Contract Development and Manufacturing Organization CDMO revenues to drop as its commitments in Denmark come to an end. #BioprocessUpdates #Biogen #CDMO #revenues #drop #Denmark #commitments #biotech #global #article #pharmaceuticals #biotechnology #manufacturing #contract #end ▷ Read the full article here: 📎 https://lnkd.in/d39xNQRT

Suven Pharmaceuticals Limited is thrilled to announce a strategic move to acquire a majority stake in Sapala Organics, a leading CDMO focused on Oligo drugs and nucleic acid building blocks. This acquisition bolsters Suven's capabilities in the rapidly growing oligonucleotide and nucleic acid market. This acquisition brings Sapala’s deep expertise in complex oligo building blocks to Suven’s diversified technology platforms, including ADCs and Oligos. Nucleic acid-based therapies target diseases at a genetic level, offering potential cures for previously incurable conditions. With this acquisition, Suven is well-positioned to lead in this transformative healthcare segment. 🔗 Read more: https://lnkd.in/g5GwfBd9 #SuvenPharma #SapalaOrganics #Pharmaceuticals #Acquisition #Oligonucleotides #Biotech #CDMO #NucleicAcids #PharmaNews

Thoughts on this? >> SK Bioscience takes majority stake in CDMO for $244M; Ex-Lonza CEO joins Cytiva >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharma #pharmaceutical #productmarketing